Repurposing anticancer drugs for the management of COVID-19

Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded as a global public health emergency. The existing therapeutic options for COVID-19 beyond the intensive supportive care are lim...

Descripción completa

Detalles Bibliográficos
Autores principales: El Bairi, Khalid, Trapani, Dario, Petrillo, Angelica, Le Page, Cécile, Zbakh, Hanaa, Daniele, Bruno, Belbaraka, Rhizlane, Curigliano, Giuseppe, Afqir, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508523/
https://www.ncbi.nlm.nih.gov/pubmed/33125946
http://dx.doi.org/10.1016/j.ejca.2020.09.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508523/
https://www.ncbi.nlm.nih.gov/pubmed/33125946
http://dx.doi.org/10.1016/j.ejca.2020.09.014

Ejemplares similares